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COMMENTARY

Lessons from an Evidence-Based Medicine Exploration:
When Transparency and Sensitivity (Analyses) Can Change
the Take-Home Message
Nadi N Kaonga, MD, MHS, MS,1 Toby Fitzgerald, DO1
1

Department of Obstetrics and Gynecology, Maine Medical Center, Portland, ME

BACKGROUND
Induction of labor is quite common in the United
States. While induction rates have declined over
the last decade, nearly 1 in 4 deliveries (23%) in
the United States is induced for medical or elective
reasons.1 Of the induction agents available,
intravenous (IV) oxytocin is used in an estimated
25% of cases.2 At our academic medical center,
40% of our labor inductions from April 2019 to
September 2019 used IV oxytocin (unpublished
data). This medication comes with high risks,
including uterine tachysystole, hyperstimulation,
fetal
distress,
hypotension,
hypertension,
hyponatremia, seizures, and coma.2
To understand our use of IV oxytocin and its impact
on birth outcomes at our institution, we conducted
a literature search and discussed the findings
in our department’s evidence-based medicine
(EBM) session (ie, journal club). We identified 4
recent articles that performed systematic reviews
evaluating birth outcomes and use of IV oxytocin. In
particular, the articles examined how discontinuing
IV oxytocin during the active phase of labor impacts
the cesarean section (C-section) rate.2,3-5 While all
4 review articles concluded that discontinuing IV
oxytocin in the active phase of labor significantly
reduced the C-section rate, 1 article conducted
sensitivity analyses that, importantly, changed
the interpretation of the primary outcome.2 With
this new interpretation, we identified important
considerations when reviewing the literature. In
this article, we share our lessons from our EBM
exploration on this topic to help inform more
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rigorous and creative approaches to interpreting
the literature.

LESSONS
Know your resources and think outside of the
box
In our Department of Obstetrics and Gynecology,
our method for EBM literature reviews is to first
identify a faculty mentor and also consider meeting
with the department’s research navigator. The
research navigator has a background in research
methods, biostatistics, and epidemiology. Given
their skillset, they serve as a resource to better
understand the clinical literature. Our department’s
research navigator helped explain and clarify the
more advanced statistical concepts in the review
articles. In our process, they also encouraged nontraditional thinking and prompted our exploration
of the supply and distribution of IV oxytocin at our
institution.
In this pursuit, we spoke with the pharmacy and
billing departments to better understand how IV
oxytocin is acquired and distributed, and what it
costs our institution and patients. To learn more
and contextualize our center’s use of IV oxytocin,
we worked with our department’s head of quality
improvement to compile data and analyze births
and inductions over a 6month period. This approach
allowed us to conceptualize the review articles’
findings within our local context.
The research navigator, pharmacy staff member
and billing representative supported the exercise,
and their additional input helped to enrich the
subsequent EBM discussion with practical cases
and considerations. We were also able to supply
evidence (albeit specific to our academic medical
1
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center) that was otherwise missing from the global
evidence base for discussion.
Read more than one article

For the purpose of our department’s EBM session,
we selected 1 review article to focus on and discuss.
While we had 1 article in mind, we conducted a
cursory review in PubMed that helped identify
4 similar review articles. Without this cursory review,
we would not have found the article by Boie et al.2
There was 78% to 100% overlap of references
between the 4 review articles, and we were able
to read the additional articles to compare methods
and findings. This process revealed a crucial, yet
overlooked, limitation and analysis in 3 of the review
articles that ultimately changed the interpretation
of the primary outcome. Boie and colleagues took
these factors into consideration in their review.
Checklists and reporting guidelines are a
helpful start
In 2 of the most recent 4 review articles,2,5 the
Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) Checklist was used
to guide the reading and appraisal of the articles.6
Both articles accounted for all items within the text
or supplementary files. However, only through
closer reading and comparison did we understand
how and why only Boie et al conducted sensitivity
analyses in their review article.
Transparency matters
Boie and colleagues were very transparent in their
reporting. They justified why they conducted specific
types of analyses. Oftentimes, their analyses were
limited by the level of reporting in the individual
studies. Accordingly, they contacted authors of
the individual studies to obtain as much detail as
possible regarding the included data.
Sensitivity analyses can be game changers
Sensitivity analyses provide the ability to assess
the robustness of a primary result and test how
the results may or may not hold based on different
assumptions.7 The sensitivity analysis conducted
by Boie and colleagues revealed a critical omission
in previous analyses of the primary outcome. While
all the review articles concluded that the C-section
rate was significantly reduced when IV oxytocin
was discontinued during the active phase of labor,
the sensitivity analysis in the Boie et al review only
included data on C-sections after the active phase.
By focusing only on these patients, they found
that discontinuing IV oxytocin in the active phase
https://knowledgeconnection.mainehealth.org/jmmc/vol2/iss2/17
of labor had little to no impact on the C-section
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rate. This finding underscores the importance of
understanding assumptions and assessing data in
different ways. Furthermore, the sensitivity analysis
conferred a greater level of certainty (moderate) but
only reflected data from 4 studies. When considering
practice, this finding was now less influential, and it
also resulted in closer critique and questioning of
the findings for the secondary outcomes.
Additionally, IV oxytocin is a high-risk medication
with several severe side effects. While its
continuation minimally reduces the time from labor
to delivery and its discontinuation does not impact
the C-section rate, a risk-benefit analysis for each
use case must be considered.

CONCLUSION
Ultimately, EBM discussions are meant to challenge
and/or inform practice. The lessons learned from
this EBM exploration are salient reminders that data
reported in articles should not be blindly accepted.
We hope that the lessons we shared in this article
will serve as a helpful starting point and approach
to more rigorous and creative EBM reflection and
discussions.
Keywords: obstetrics, oxytocin, induction, labor,
evidence-based medicine
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